148 related articles for article (PubMed ID: 16480270)
21. Quantitative structure-activity relationship of organosulphur compounds as soybean 15-lipoxygenase inhibitors using CoMFA and CoMSIA.
Caballero J; Fernández M; Coll D
Chem Biol Drug Des; 2010 Dec; 76(6):511-7. PubMed ID: 21040497
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors.
Bakavoli M; Nikpour M; Rahimizadeh M; Saberi MR; Sadeghian H
Bioorg Med Chem; 2007 Mar; 15(5):2120-6. PubMed ID: 17210254
[TBL] [Abstract][Full Text] [Related]
23. Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.
Kenyon V; Rai G; Jadhav A; Schultz L; Armstrong M; Jameson JB; Perry S; Joshi N; Bougie JM; Leister W; Taylor-Fishwick DA; Nadler JL; Holinstat M; Simeonov A; Maloney DJ; Holman TR
J Med Chem; 2011 Aug; 54(15):5485-97. PubMed ID: 21739938
[TBL] [Abstract][Full Text] [Related]
24. Caulerpenyne and related bis-enol esters are novel-type inhibitors of human 5-lipoxygenase.
Richter P; Schubert G; Schaible AM; Cavas L; Werz O; Pohnert G
ChemMedChem; 2014 Aug; 9(8):1655-9. PubMed ID: 24729578
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanism of 15-lipoxygenase allosteric activation and inhibition.
Meng H; Dai Z; Zhang W; Liu Y; Lai L
Phys Chem Chem Phys; 2018 May; 20(21):14785-14795. PubMed ID: 29780994
[TBL] [Abstract][Full Text] [Related]
26. Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase.
Tirapegui C; Acevedo-Fuentes W; Dahech P; Torrent C; Barrias P; Rojas-Poblete M; Mascayano C
Bioorg Med Chem Lett; 2017 Apr; 27(8):1649-1653. PubMed ID: 28318946
[TBL] [Abstract][Full Text] [Related]
27. Development of 3,5-dinitrobenzoate-based 5-lipoxygenase inhibitors.
Shang E; Liu Y; Wu Y; Zhu W; He C; Lai L
Bioorg Med Chem; 2014 Apr; 22(8):2396-402. PubMed ID: 24685113
[TBL] [Abstract][Full Text] [Related]
28. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
[TBL] [Abstract][Full Text] [Related]
29. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
[TBL] [Abstract][Full Text] [Related]
30. Photoactivation of an inhibitor of the 12/15-lipoxygenase pathway.
Herre S; Schadendorf T; Ivanov I; Herrberger C; Steinle W; Rück-Braun K; Preissner R; Kuhn H
Chembiochem; 2006 Jul; 7(7):1089-95. PubMed ID: 16755628
[TBL] [Abstract][Full Text] [Related]
31. Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.
Rai G; Joshi N; Jung JE; Liu Y; Schultz L; Yasgar A; Perry S; Diaz G; Zhang Q; Kenyon V; Jadhav A; Simeonov A; Lo EH; van Leyen K; Maloney DJ; Holman TR
J Med Chem; 2014 May; 57(10):4035-48. PubMed ID: 24684213
[TBL] [Abstract][Full Text] [Related]
32. Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes.
Filosa R; Peduto A; Schaible AM; Krauth V; Weinigel C; Barz D; Petronzi C; Bruno F; Roviezzo F; Spaziano G; D'Agostino B; De Rosa M; Werz O
Eur J Med Chem; 2015 Apr; 94():132-9. PubMed ID: 25765759
[TBL] [Abstract][Full Text] [Related]
33. The potential of 12/15-lipoxygenase inhibitors in stroke therapy.
van Leyen K; Holman TR; Maloney DJ
Future Med Chem; 2014; 6(17):1853-5. PubMed ID: 25495979
[No Abstract] [Full Text] [Related]
34. Active site characterization and structure based 3D-QSAR studies on non-redox type 5-lipoxygenase inhibitors.
Ul-Haq Z; Khan N; Zafar SK; Moin ST
Eur J Pharm Sci; 2016 Jun; 88():26-36. PubMed ID: 27044904
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory activity of salicylic acid on lipoxygenase-dependent lipid peroxidation.
Lapenna D; Ciofani G; Pierdomenico SD; Neri M; Cuccurullo C; Giamberardino MA; Cuccurullo F
Biochim Biophys Acta; 2009 Jan; 1790(1):25-30. PubMed ID: 18950686
[TBL] [Abstract][Full Text] [Related]
36. Oleyl sulfate reveals allosteric inhibition of soybean lipoxygenase-1 and human 15-lipoxygenase.
Mogul R; Johansen E; Holman TR
Biochemistry; 2000 Apr; 39(16):4801-7. PubMed ID: 10769137
[TBL] [Abstract][Full Text] [Related]
37. Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase.
Dianat S; Moghimi S; Mahdavi M; Nadri H; Moradi A; Firoozpour L; Emami S; Mouradzadegun A; Shafiee A; Foroumadi A
J Enzyme Inhib Med Chem; 2016; 31(sup3):205-209. PubMed ID: 27424740
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors.
Jabbari A; Davoodnejad M; Alimardani M; Assadieskandar A; Sadeghian A; Safdari H; Movaffagh J; Sadeghian H
Bioorg Med Chem; 2012 Sep; 20(18):5518-26. PubMed ID: 22917856
[TBL] [Abstract][Full Text] [Related]
39. Human 15-lipoxygenase: induction by interleukin-4 and insights into positional specificity.
Sigal E; Sloane DL; Conrad DJ
J Lipid Mediat; 1993; 6(1-3):75-88. PubMed ID: 8358018
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]